v3 Template
B

BellaSeno GmbH

Medical Device / Regenerative Medicine Leipzig, Germany / Brisbane, Australia ~620 employees
Founded
--
Employees (Est.)
~620
31 leaders known
Total Funding
$415.5M
Funding Rounds
1
Last Funding
2024-06-05

About BellaSeno GmbH

BellaSeno is a clinical-stage medical device company focused on revolutionizing regenerative medicine through proprietary design and additive manufacturing platforms. They create fully absorbable implants (scaffolds) that support natural tissue growth and are absorbed by the body over time, aiming to make healing efficient, natural, and accessible while changing global healthcare standards.

Products & Services

Breast Reconstruction Scaffolds:Next-generation fully absorbable breast scaffolds for breast reconstruction, augmentation, and revision surgeries, made from a clinically validated polymer that is replaced by natural tissue over time.
Chest-Wall Defects Scaffolds:Custom-made, fully absorbable Pectus scaffolds designed with expert engineers and surgeons to camouflage complex chest wall defects.
Trauma & Orthopaedics Scaffolds:Custom-made, absorbable scaffolds designed to maximize bone graft retention and packing effectiveness for large and complex bone defects.

Specialties

Additive Manufacturing Absorbable Implants Soft Tissue Reconstruction Breast Reconstruction Chest-Wall Defects Trauma & Orthopaedics

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 415500000
MR: -
FA: $415.5 million
FAN: 415500000
D: 2024-06-05
FD: 2024-06-05
1 investors
Grant Latest
2024-06-05
$415.5M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

Dr. Mohit P. Chhaya

Chief Executive Officer (CEO) / Co-Founder

D

Dr. med. Tobias Grossner

Chief Medical Officer (CMO)

D

Dr. Thomas Lingner

Chief Technology Officer

S

Sanat Dimetriou-Dickson

Chief Marketing Officer

H

Herbert Stadler, PhD

Chairman Supervisory Board / Series A+B Investor

D

Dr. Mark L. Jewell

Clinical Advisor

View 28 more team members with Pro

Unlock Full Team Directory

Recent News

BellaSeno GmbH Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Medical Device / Regenerative Medicine
Company Size
~620 employees (est.)
Locations
Leipzig, Germany / Brisbane, Australia
Leipzig, Germany and Brisbane, Australia

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro